APA (7th ed.) Citation

Liu, Y., Yao, Y., Yang, X., Wei, M., Lu, B., Dong, K., . . . Pan, X. (2024, January). Lymphocyte activation gene 3 served as a potential prognostic and immunological biomarker across various cancer types: A clinical and pan‐cancer analysis. Clinical & Translational Immunology.

Chicago Style (17th ed.) Citation

Liu, Yifan, et al. "Lymphocyte Activation Gene 3 Served as a Potential Prognostic and Immunological Biomarker Across Various Cancer Types: A Clinical and Pan‐cancer Analysis." Clinical & Translational Immunology Jan. 2024.

MLA (9th ed.) Citation

Liu, Yifan, et al. "Lymphocyte Activation Gene 3 Served as a Potential Prognostic and Immunological Biomarker Across Various Cancer Types: A Clinical and Pan‐cancer Analysis." Clinical & Translational Immunology, Jan. 2024.